Skip to main content

 

 

37

Total Releases

Cordlife Group's Cord Lining, Cord Tissue, Cord Tissue Mesenchymal Stem Cell Release Track Record

The table below features the cord lining, cord tissue or cord tissue mesenchymal stem cell releases performed by Cordlife Group Limited and its subsidiaries.

As a Group, Cordlife has made 37 cord lining, cord tissue or cord tissue mesenchymal stem cell releases, all of which have been used successfully in cellular therapy.

NoYear of ReleaseIndication(s)Unit Used ByVial UsedSTORAGE TIME (MONTHS)Storage CountryHEALTHCARE INSTITUTION
12015Cerebral PalsySelf1 vial7.1IndonesiaRS Mayapada
22016Cerebral PalsySibling1 vial12.3IndonesiaRS Harapan Kita / RS Mayapada
32017DementiaGrandfather2 vials3.6IndonesiaRS Medistra
42017Spina BifidaSibling1 vial10.8IndonesiaRS PON
52018Cerebral PalsySibling1 vial7.7IndonesiaRS Cipto Mangunkusumo
62018DiabetesGrandfather1 vial16.7IndonesiaRS Medistra
72019Kidney DiseaseGrandfather1 vial26.8IndonesiaVinski Regenerative Centre
82021StrokeGrandfather1 vial5.5IndonesiaVinski Regenerative Centre
9*2022Fatty Liver DiseaseFather1 vial17.3PhilippinesPrivate hospital, Philippines
10*2022Chronic Kidney DiseaseGrandfather2 vials17.3PhilippinesPrivate hospital, Philippines
112022Cerebral PalsySibling1 vial10.5IndonesiaPrivate hospital, Indonesia
12*2023Diabetes MellitusGrandmother1 vial20.0PhilippinesPrivate hospital, Philippines
13*2023Diabetes MellitusUncle1 vial20.0PhilippinesPrivate hospital, Philippines
14*2023Chronic Kidney DiseaseFather1 vial2.6PhilippinesPrivate hospital, Philippines
15*2023Osteoarthirtis & Diabetes MellitusGrandfather1 vial7.5PhilippinesPrivate hospital, Philippines
162023Diabetes MellitusGrandfather1 vial10.5IndonesiaTerra Clinic/ Beauty Inc.
17*2023Chronic Kidney DiseaseUncle1 vial9.7PhilippinesPrivate hospital, Philippines
182023Autism Spectrum DisorderSibling1 vial7.7IndonesiaCelltech Stem Cell Centre
192023Symptoms of Speech Delay and AutismChild1 vial88.0IndonesiaCelltech Stem Cell Centre
202024ASDSibling2 vials10.2IndonesiaJakarta Clinic
212024Symptoms of type II Diabetes MellitusFather (of the baby)2 vials45.9IndonesiaCelltech Stem Cell Centre, Jakarta
222024StrokeFather (of the baby)4 vials151.2IndonesiaCelltech Stem Cell Centre, Jakarta
232024OthersGrandparent (of the baby)1 vial61.3IndonesiaAmnion Clinic, Jakarta
242024OthersGrandparent (of the baby)1 vial61.3IndonesiaAmnion Clinic, Jakarta
252025OthersGrandmother2 vials10.1IndonesiaAmnion Clinic, Jakarta
262025Diabetes Melitus (DM)Grandfather0.67 vials24.4IndonesiaSCCR, Semarang
272025AllergyAunt0.67 vials24.4IndonesiaSCCR, Semarang
282025Post Laminoplasty CervicalAunt0.67 vials24.4IndonesiaSCCR, Semarang
292025Kidney FailureGrandfather2 vials64.3IndonesiaCelltech Stem Cell Centre, Jakarta
30*2026OthersGrandfather (of the baby)6 vials21.1PhilippinesPrivate hospital, Philippines
312026Autoimmune diseasesSelf2 vials89.3IndonesiaCelltech Stem Cell Centre, Jakarta
32*2026Osteoarthirtis & Diabetes MellitusGrandfather (of the baby)2 vials28.0PhilippinesPrivate hospital, Philippines
33*2026Diabetes MellitusGreat aunt (of the baby)2 vials9.0PhilippinesPrivate hospital, Philippines
34*2026Dyslipidemia Diabetes MellitusFather (of the baby)2 vials9.0PhilippinesPrivate hospital, Philippines
352026OthersNA3 vials6.7IndonesiaAsia Stem Cell
36*2026NANA1 vial11.0PhilippinesPrivate hospital, Philippines
37*2026Pre-diabetesFather (of the baby)6 vials23.0PhilippinesPrivate hospital, Philippines

*Ready-to-use mesenchymal stem cells stored with Cordlife.

Footnotes:

  • This list shows the cord lining, cord tissue or cord tissue mesenchymal stem cells released by Cordlife and its subsidiaries to support the treatment of various diseases. This should not be used as a reference for the list of treatable diseases by cord lining, cord tissue or cord tissue mesenchymal stem cells. In addition, banking your baby’s cord lining, cord tissue or cord tissue mesenchymal stem cells does not guarantee that the stem cells will provide a cure or be applicable for every situation. The use is ultimately determined by the treating physician.
  • Some releases may be for the same client but released in different period.
  • Indications categorised under "others" included anti-aging therapy (n=4), and wellness (n=1).

DCR 3636
Implementation Date 5-May-2026

Getting Started

FREE Info Pack

Download Cordlife’s info pack on umbilical cord stem cell banking for free.

FREE Consultation

Have a free consultation with Cordlife stem cell banking consultants.

Refer a friend

Share the benefits of cord blood banking with your friends today!

Why you should consider umbilical cord lining banking for your baby

Umbilical cord lining stem cells have immune-modulating characteristics. Therefore matching of stem cells between donor and the patient may not be required, which makes them useful both for your baby and other members in the family.

Umbilical cord lining stem cells can also help increase the success rate of stem cell transplant. It contains two types of stem cells – Mesenchymal (MSCs) and Epithelial (EpSCs) Stem Cells, which can be used to support multiple medical treatments whenever needed.

With umbilical cord lining stem cells, your baby and family members will have more treatment options in the future, especially for disorders* that are incurable today such as stroke and heart attack.

Compared to other sources such as bone marrow and adipose tissue, stem cells from umbilical cord lining are younger with better expansion capacity and patients receiving such as stem cells have lower risk of graft versus host disease.

Using cryogenic storage method, umbilical cord lining can remain viable for a long time. This means that the therapeutic value of umbilical cord lining stem cells are well-preserved until the need for treatment arises.

Your baby has one chance to have his/her umbilical cord lining collected as this painless and harmless process must be done at birth.